National Sarcoma Forum

NSF Stream at BSG Annual Conference 2019

The purpose of the NSF is to provide members with support, education and an opportunity for networking and to provide a national voice on clinical and strategic issues.

For sarcoma clinical nurse specialists (CNS) and allied professionals.

The National Sarcoma Forum (NSF) was set up in 2011. It is a formal group for all clinical nurse specialists and allied professionals working in the sarcoma field (who spend a third or more of their working time with sarcoma patients).

The National Sarcoma Forum holds an annual study day as part of the British Sarcoma Group Conference. For more information about BSG Conference please click HERE.


Membership of the NSF is open to nurse specialists/AHPs/key workers in academic or research roles related to sarcoma. NSF Membership has been formalised and now sits as a strand of British Sarcoma Group Membership.

To join the BSG and the NSF, please complete our online membership form.


Membership is free and gives the following benefits:

  • Become part of an engaged community of fellow specialists seeking to improve sarcoma treatment
  • Access member surveys and research
  • Help influence national guidelines on best practice
  • Join a national network of those working to treat sarcoma
  • Benefit from educational opportunities
  • Receive regular newsletters and updates from us


The activities of the NSF fall into four distinct categories:

  • Clinical: Improving sarcoma patient care; dissemination of best practice; sharing information & knowledge.
  • Developmental: Highlighting new national developments; supporting colleagues new in post; involvement at national level with the development of the role; bench marking.
  • Educational: Providing a forum to update on new developments, and to discuss research/best practice.
  • Professional: Providing support and networking opportunities; providing a national voice on clinical and strategic issues; highlighting the uniqueness of nursing/AHP input for patients with sarcoma.